Tag: KNSA

Analysts Viewpoint

Analyzing Kiniksa Pharmaceuticals International Plc (KNSA) After Recent Trading Activity

Kiniksa Pharmaceuticals International Plc’s recent filing unveils that its CHIEF FINANCIAL OFFICER Ragosa Mark unloaded Company’s shares for reported $0.37

Analysts Viewpoint

KNSA Stock Sees Decline of Approximately -1.89% in Last Five Days

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Selling Buzz: Kiniksa Pharmaceuticals International Plc [KNSA] CHIEF FINANCIAL OFFICER Ragosa Mark sells 11,464 shares of the company

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kiniksa Pharmaceuticals